Probi AB listed at Stockholm Stock Exchange

As of today, the biotechnology company Probi AB is listed on the Stockholm Stock Exchange’s O list.

Probi is a biotech company that develops and patents probiotic bacteria for use in nutritional products. The probiotic bacteria are licensed to players within functional food, dietary supplements and clinical nutrition. Probi was founded in 1991 and has its’ headoffice in Lund, Sweden. “We warmly welcome Probi to Stockholm Stock Exchange,” says Henrik Paulsson, acting President of Stockholm Stock Exchange. Per Bengtsson, CEO of Probi AB, comments: " The listing on the Stockholm Stock Exchange’s O list will form the basis for a sound liquidity in the Probi-share. We also believe that the listing will strengthen the confidence in Probi among our customers and partners." Photos from the welcoming ceremony and a web cast interview with Probi’s CEO Per Bengtsson, are available on www.omxgroup.com/stockholmsborsen under Corporate actions, Changes in listed companies and listings. Information about the industry classification and similar details is also available on www.omxgroup.com/stockholmsborsen under Corporate actions and Press Releases and Exchange Notices/Search/Equity related information.